Substandard and counterfeit medicines: a systematic review of the literature.
about
Combating poor-quality anti-malarial medicines: a call to actionClinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimodSubstandard/counterfeit antimicrobial drugsInterventions to combat or prevent drug counterfeiting: a systematic reviewQuality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chainTechnologies for detecting falsified and substandard drugs in low and middle-income countries.Treatment of infections in young infants in low- and middle-income countries: a systematic review and meta-analysis of frontline health worker diagnosis and antibiotic accessGood quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosisQuality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, NigeriaThe Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in TanzaniaAssessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLabĀ®: a field studyResponding to the pandemic of falsified medicines.Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern MalawiPublic health measures to fight counterfeit medicine market.Erroneous formulation of delayed-release omeprazole capsules: alert for importing countriesAnti-malarial medicine quality field studies and surveys: a systematic review of screening technologies used and reporting of findings.Quality assurance of medicines supplied to low-income and middle-income countries: poor products in shiny boxes?Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countriesIn vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh.The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines.Quality of oxytocin available in low- and middle-income countries: a systematic review of the literature.Prevalence estimates of substandard drugs in Mongolia using a random sample survey.Improving antibiotic prescribing for children in the resource-poor setting.Patient Knowledge on Malaria Symptoms Is a Key to Promoting Universal Access of Patients to Effective Malaria Treatment in Palawan, the Philippines.Quality of the antibiotics--amoxicillin and co-trimoxazole from Ghana, Nigeria, and the United Kingdom.Counterfeit drug penetration into global legitimate medicine supply chains: a global assessmentSubstandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings.Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.Laboratory-based nationwide surveillance of antimicrobial resistance in GhanaThe diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs.Physicochemical equivalence of generic antihypertensive medicines (EQUIMEDS): protocol for a quality of medicines assessmentExamining the Quality of Medicines at Kenyan Healthcare Facilities: A Validation of an Alternative Post-Market Surveillance Model That Uses Standardized Patients.Pervasive antibiotic misuse in the Cambodian community: antibiotic-seeking behaviour with unrestricted access.Antibiotic-associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study.Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013)Global analysis of strategies to tackle antimicrobial resistance.Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy.How safe is paracetamol?
P2860
Q24658634-A9704404-C737-42AA-A186-A84539A26616Q26740235-A07A1082-45ED-4010-A69C-E09D2EF0A184Q27009319-9AD6DA93-233C-483E-B4AA-5876C6A64E5AQ27010468-8575149E-566F-4A74-967F-14B687FEC0CDQ28538830-3717CB84-CA8F-48D2-84CD-1F330FC251C7Q28541540-5C9B2E54-A2DA-4C41-926E-C8BD31950CC9Q28543733-A5147BE0-8A38-4FC9-8B3C-618FBB8BE8EDQ28546831-38CC2998-7BEA-4C19-B1A3-DC8E8FDE94B0Q28547513-28D47975-20FE-4777-AA6F-303B0C126FF2Q28553535-2A6FD938-944E-4759-B294-514A054DA8A6Q28647142-CFF7A7A3-4006-451A-91BF-71B6F6E492FAQ30062161-0B4C5A2A-A5F6-4D0F-B935-E227D4190DA3Q30377168-8FA5E0EA-28CA-435E-AEB4-FFCE70B4A44BQ33600920-D00F7500-AB59-493C-8742-23A9A46C5B0DQ33634731-2203494F-CCBD-4CFB-B89E-6F4FFF5573EFQ33691830-C18F31DB-DDFC-4E95-9EE2-77FA5BAB5161Q33699168-A8EA8295-BAB2-467B-A623-8002798566FEQ33726606-B0205842-B36D-47A8-9E62-5B3A9C5AC08FQ33742784-1851D22D-B0B7-43C9-A88C-2E151ED989EFQ33814580-C2FE6359-3902-471B-A964-F3D4EFDBF16EQ34519439-23A29C87-0BD0-402F-BF0A-ED377716A733Q34697207-E14381B5-F01B-45CB-884C-FB17333B1300Q35135959-3E8FE36F-25E3-48C5-A85D-A680C3DE2C85Q35664861-BAEC80E5-7C57-46C9-AC2B-371D6DBC2168Q35681789-8B73EDB7-5261-4E4A-8A19-C84C37FF6366Q35681817-8121FC92-A9AD-40A4-8F2C-DDE974D9820DQ35681822-23422F47-F311-4AF0-99AE-4EE5EF155FB2Q36249454-0E9425EB-C82A-490A-BACA-31AF70615E8EQ36307180-A90286A2-C005-4D84-80F7-C978140F5D44Q36686951-47D2FF7F-4B98-4D76-BD9A-AD874E7087CFQ37659754-70A54B40-8317-4438-A079-75AFA5681234Q37675225-C4225F4E-9BCA-46AC-908C-68D62124719EQ37720964-7369FFA8-63F2-4978-BC0F-279C043F230EQ37724292-7AB641EB-22D1-4CE9-BDA3-F6C0433E6332Q38264191-BC020BCD-7067-49A0-93A3-9AC1C1614301Q38860530-D90A471E-8EDF-4A38-B92B-7AC8E2E74694Q38867438-60EBDB85-E053-435B-BC89-0F323EDAA178Q41634918-EB79E216-770E-4033-A35D-D4D66A2AE1D6Q42370094-119D5D1C-FBAA-4B3F-BA95-FFDFD2B41CF6Q42740842-61E31B0E-CAB3-4BE8-8D77-CAB893BD134F
P2860
Substandard and counterfeit medicines: a systematic review of the literature.
description
article cientĆfic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo cientĆfico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2013
@en
vedeckĆ½ ÄlĆ”nok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vÄdeckĆ½ ÄlĆ”nek
@cs
name
Substandard and counterfeit medicines: a systematic review of the literature.
@en
Substandard and counterfeit medicines: a systematic review of the literature.
@nl
type
label
Substandard and counterfeit medicines: a systematic review of the literature.
@en
Substandard and counterfeit medicines: a systematic review of the literature.
@nl
prefLabel
Substandard and counterfeit medicines: a systematic review of the literature.
@en
Substandard and counterfeit medicines: a systematic review of the literature.
@nl
P2860
P1433
P1476
Substandard and counterfeit medicines: a systematic review of the literature.
@en
P2093
Helen Sammons
Tariq Almuzaini
P2860
P304
P356
10.1136/BMJOPEN-2013-002923
P577
2013-08-17T00:00:00Z